Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carboplatin/Gemcitabine Followed by Paclitaxel vs Cisplatin/Vinorelbine Followed by Docetaxel in Advanced NSCLC
NCT00003587Phase 2Completed
- Sponsor
- SWOG Cancer Research Network
- Start
- Oct 1998
- Primary completion
- Jan 2001
- Modality
- Nanoparticles, DNA Intercalators/Alkylators, Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of carboplatin, gemcitabine, Paclitaxel Micelles for Injection, Cisplatin micelle injection (HA132), vinorelbine in non-small cell lung cancer (NSCLC), sponsored by SWOG Cancer Research Network. Started Oct 1998; status: completed.
02
Drugs
carboplatingemcitabinePaclitaxel Micelles for InjectionCisplatin micelle injection (HA132)vinorelbine
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00003587.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003587.